Joanne Goodwin

Sheffield, ENG S102JF, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

NCGS like IBS 'type' symptoms is a diagnosis of exclusion.

NCGS like IBS 'type' symptoms is a diagnosis of exclusion.

Journal: Nutrition journal

Published: June 06, 2021

Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study.

Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study.

Journal: Antimicrobial agents and chemotherapy

Published: November 04, 2018

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.

Journal: The Journal of antimicrobial chemotherapy

Published: December 01, 2015

Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates.

Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates.

Journal: The Journal of antimicrobial chemotherapy

Published: July 16, 2015

Pharmacodynamics of Isavuconazole in a Dynamic In Vitro Model of Invasive Pulmonary Aspergillosis.

Pharmacodynamics of Isavuconazole in a Dynamic In Vitro Model of Invasive Pulmonary Aspergillosis.

Journal: Antimicrobial agents and chemotherapy

Published: June 10, 2015

Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance.

Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance.

Journal: Antimicrobial agents and chemotherapy

Published: April 01, 2015

Pharmacodynamics of amphotericin B deoxycholate, amphotericin B lipid complex, and liposomal amphotericin B against Aspergillus fumigatus.

Pharmacodynamics of amphotericin B deoxycholate, amphotericin B lipid complex, and liposomal amphotericin B against Aspergillus fumigatus.

Journal: Antimicrobial agents and chemotherapy

Published: November 05, 2014

Pulmonary penetration of piperacillin and tazobactam in critically ill patients.

Pulmonary penetration of piperacillin and tazobactam in critically ill patients.

Journal: Clinical pharmacology and therapeutics

Published: March 10, 2014

Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days.

Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days.

Journal: mBio

Published: January 30, 2014

In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.

In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.

Journal: Antimicrobial agents and chemotherapy

Published: September 18, 2013

Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa.

Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa.

Journal: Antimicrobial agents and chemotherapy

Published: September 05, 2013

Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients.

Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients.

Journal: The Journal of infectious diseases

Published: April 20, 2013

Showing 1-12 of 20

Last Updated: 09/26/2026